Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
GoodRx is now publicly available to trade. The stock opened at $46, nearly 40% above it's IPO price of $33.
Launched in 2011, GoodRx allows customers to compare prescription drug prices. It's since become a household name, which may be one of the reasons that the stock has been getting so much buzz. If you're planning to invest, here's how you can buy in.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $6.54 |
|---|---|
| 52-week range | $3.82 - $20.59 |
| 50-day moving average | $5.39 |
| 200-day moving average | $5.70 |
| Wall St. target price | $6.93 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.09 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $6.54 from 2023-03-17
| 1 week (2023-03-09) | N/A |
|---|---|
| 1 month (2023-02-17) | 23.63% |
| 3 months (2022-12-16) | N/A |
| 6 months (2022-09-16) | N/A |
| 1 year (2022-03-16) | -58.63% |
|---|---|
| 2 years (2021-03-19) | -82.47% |
| 3 years (2020-03-16) | N/A |
| 5 years (2018-03-16) | N/A |
Valuing Goodrx Holdings Inc stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Goodrx Holdings Inc's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
To put Goodrx Holdings Inc's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $766.6 million |
|---|---|
| Operating margin TTM | 5.15% |
| Gross profit TTM | $701.5 million |
| Return on assets TTM | 1.54% |
| Return on equity TTM | -3.99% |
| Profit margin | -4.28% |
| Book value | $2.05 |
| Market capitalisation | $2.5 billion |
TTM: trailing 12 months
We're not expecting Goodrx Holdings Inc to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Goodrx Holdings Inc's shares have ranged in value from as little as $3.82 up to $20.59. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Goodrx Holdings Inc's is 0.851. This would suggest that Goodrx Holdings Inc's shares are less volatile than average (for this exchange).
To put Goodrx Holdings Inc's beta into context you can compare it against those of similar companies.
GoodRx Holdings, Inc. , through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is headquartered in Santa Monica, California.
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.